Landiao, Cherilyn S.
HRN: 17-58-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/04/2024
03/10/2024
IVTT
500 Mg
Q8
Amoebic Dysentery
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes